[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ischemic-ulcer\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ischemic-ulcer":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":4,"targetDuration":4,"studyType":17,"phases":4,"briefSummary":18,"conditions":19,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":4,"completionDateStruct":4,"leadSponsor":32,"locationsCount":5},"100572188","dermacyte-liquid-for-treatment-of-cutaneous-ulcers-and-wounds-100572188",false,"NCT06730022","Dermacyte® Liquid for Treatment of Cutaneous Ulcers and Wounds","Inclusion Criteria:\n\n* Must be 18 years of age or older\n* Must have a cutaneous ulcer or wound refractory to initial treatment or does not have an adequate treatment alternative, as determined by the Investigator\n\nExclusion Criteria:\n\n* Must not be pregnant or lactating\n* Must not have known malignancies\n* Must not be less than 18 years of age","ALL","18 Years","EXPANDED_ACCESS","The objective of this study is to make Dermacyte Liquid available on an expanded access basis to treat cutaneous ulcers and wounds refractory to initial treatment or that do not have adequate alternative treatments. Minimal data will be collected to evaluate the efficacy and safety of Dermacyte Liquid.",[20,21,22,23,24,25,26],"Cutaneous Ulcer","Diabetic Ulcer","Surgical Wound Dehiscence","Burns - Multiple","Pressure Ulcers","Mixed Ulcer","Ischemic Ulcer","AVAILABLE","2025-02-21",{"date":30,"type":31},"2025-02-25","ACTUAL",{"name":33,"class":34},"Merakris Therapeutics","INDUSTRY"]